North America Flu Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

SKU ID : GIR- 10773193

Publishing Date : 11-Dec-2017

No. of pages : 122

PRICE
4480
8960


  • Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.


    Scope of the Report:
    This report focuses on the Flu Vaccine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

    Market Segment by Manufacturers, this report covers
    CSL
    GSK
    Sanofi Pasteur
    Mylan
    AstraZeneca
    Pfizer
    Johnson & Johnson

    Market Segment by Countries, covering
    United States
    Canada
    Mexico

    Market Segment by Type, covers
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines
    Live Attenuated Virus Vaccines

    Market Segment by Applications, can be divided into
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

    There are 15 Chapters to deeply display the North America Flu Vaccine market.

    Chapter 1, to describe Flu Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of Flu Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Flu Vaccine, for each country, from 2012 to 2017;

    Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

    Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

    Chapter 10, Flu Vaccine market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

    Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

    Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

    Chapter 13, to describe sales channel, distributors, traders, dealers etc.

    Chapter 14 and 15, to describe Flu Vaccine Research Findings and Conclusion, Appendix, methodology and data source